Interesting Review of Tamoxifen vs. AI study results
|
Re: Interesting Review of Tamoxifen vs. AI study results
Interesting..and a little disturbing, given the fact that mom had only Arimidex. Mom's current onc is a fan of tamoxifen. He uses it in an in-house protocol that is also applied to ER neg breast cancer as well as other cancers. Kind of a rotation of Taxanes with Tamoxifen synergizing at an ER independent level.
I remember when I was first learning of SERMs and AIs. I asked about combining the two since they work in different ways and was told "that isn't done". I wonder if this article is pointing to the idea that Tamoxifen up front diminishes the receptor/receiver so that AIs, working at the source/supply, have a better chance. Eventually I bet they will find Fulvestrant to be better than Tamoxifen in adjuvant since it permanently obliterates the receptor. |
Re: Interesting Review of Tamoxifen vs. AI study results
Ha! Speak of the devil! Arimidex WITH Faslodex trial:
http://clinicaltrials.gov/ct2/show/NCT00570323 |
All times are GMT -7. The time now is 10:34 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021